Opill and WNBA Team Up for Groundbreaking Partnership
GRAND RAPIDS, Mich. and NEW YORK, April 9, 2024 /PRNewswire/ -- Today, Perrigo Company plc, a leading provider of Consumer Self-Care Products, announced that Opill® — the first-ever daily birth control pill available without a prescription in the U.S. — and the Women's National Basketball Association (WNBA) have entered a multi-year partnership that focuses on building confidence, strength and health equity, all of which closely align with both organizations' core priorities.
- "Opill® is changing the game in reproductive health, just like the WNBA's game-changing role in sports and pop culture," said Leila Bahbah, Perrigo U.S. Women's Health Brand Lead.
- Opill® will tip off the relationship as an Associate Partner of the 2024 WNBA Draft presented by State Farm on April 15 in Brooklyn, New York.
- This season, the WNBA is concentrating its social justice efforts into two areas: civic engagement and reproductive health advocacy.
- Opill® and the WNBA are also collaborating on a program to reach students on college campuses nationwide.